Sartorius AG (SRT3)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

€210.60

Buy

€210.90

arrow-down€-1.00 (-0.47%)

Prices updated at 01 Apr 2026, 12:08 CEST
| Prices minimum 15 mins delay
|
Prices in EUR

Sartorius AG is a pharmaceutical and laboratory equipment supplier for biopharmaceutical production and laboratory environments. Its business is subdivided into two divisions, Bioprocess Solution, and Lab Products & Services.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Dietmar Muller
CEO
-
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
13,795
Head office
Otto-Brenner-Strasse 20
Gottingen
Germany
37079
mobile
+49 5513080
letter
info@sartorius.com

Key personnel

Salary
Professor Dr. David Raymond Ebsworth, PhD
Member of the Supervisory Board
-
Professor Dr. Klaus Ruediger Trutzschler
Member of the Supervisory Board
-
Dr. Lothar Kappich
Chairman of the Supervisory Board
-
Ms. Annette Becker
Member of the Supervisory Board
-
Dr. Daniela Favoccia
Member of the Supervisory Board
-
Mr. Dietmar Muller
Deputy Chairman of the Supervisory Board
-
Ms. Ilke Hildegard Panzer
Member of the Supervisory Board
-
Mr. Hermann Jens Ritzau
Member of the Supervisory Board
-
Mr. Frank Riemensperger
Member of the Supervisory Board
-
Ms. Sabrina Wirth
Member of the Supervisory Board
-
Ms. Beatrix Henseler
Member of the Supervisory Board
-
Mr. Dominik Langosch
Member of the Supervisory Board
-

Top 5 shareholders

No. of shares
AXA Pension 2033-203547,863,782
Vanguard1,372,250
Vanguard International Growth Fund1,283,394
Union Investment Privatfonds GmbH724,259
BlackRock Asset Management Deutschland AG - ETF535,587

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.